20250179073. Tricyclic (Ascentage Pharma (Suzhou) ., .)
TRICYCLIC HETEROCYCLE COMPOUNDS AS IAP ANTAGONISTS
Abstract: the present disclosure relates to compounds that inhibit iap (preferably ciap1, ciap2 or xiap) protein, pharmaceutical compositions comprising the same and methods of using the iap protein inhibitors in the treatment of diseases and conditions wherein inhibition of iap protein provides a benefit.
Inventor(s): Jiantao Hu, Jianyong Chen, Fang Liu, Leilei Zhao, Baolin He, Hao Chen, Xianchan Zha, Rubin Zhou, Jun Zhang, Jiawei Wang, Huifang Shi
CPC Classification: C07D471/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))
Search for rejections for patent application number 20250179073
Categories:
- Patent Applications
- Ascentage Pharma (Suzhou) Co., Ltd.
- CPC C07D471/14
- Jiantao Hu of Suzhou, Jiangsu CN
- Jianyong Chen of Suzhou, Jiangsu CN
- Fang Liu of Suzhou, Jiangsu CN
- Leilei Zhao of Suzhou, Jiangsu CN
- Baolin He of Suzhou, Jiangsu CN
- Hao Chen of Suzhou, Jiangsu CN
- Xianchan Zha of Suzhou, Jiangsu CN
- Rubin Zhou of Suzhou, Jiangsu CN
- Jun Zhang of Suzhou, Jiangsu CN
- Jiawei Wang of Suzhou, Jiangsu CN
- Huifang Shi of Suzhou, Jiangsu CN